Discovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitors | |
Li, Zizhou1,2; Xiao, Senhao2,3,4; Yang, Yaxi1,2; Chen, Chao1,2; Lu, Tian2,3; Chen, Zhifeng3; Jiang, Hualiang3; Chen, Shijie3; Luo, Cheng2,3; Zhou, Bing1 | |
刊名 | JOURNAL OF MEDICINAL CHEMISTRY |
2020-04-23 | |
卷号 | 63期号:8页码:3956-3975 |
ISSN号 | 0022-2623 |
DOI | 10.1021/acs.jmedchem.9b01784 |
通讯作者 | Luo, Cheng(cluo@simm.ac.cn) ; Zhou, Bing(zhoubing@simm.ac.cn) |
英文摘要 | The bromodomain and extra-terminal (BET) family proteins have recently emerged as promising drug targets for cancer therapy. In this study, identification of an 8-methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one fragment (47) as a new binder to the BET bromodomains and the subsequent incorporation of fragment 47 to the scaffold of ABBV-075, which recently entered Phase I clinical trials, enabled the generation of a series of highly potent BET bromodomain inhibitors. Further druggability optimization led to the discovery of compound 38 as a potential preclinical candidate. Significantly, compared with ABBV-075, which exhibits a 63-fold selectivity for BRD4(1) over EP300, compound 38 demonstrates an excellent selectivity for the BET bromodomain family over other bromodomains, with an similar to 1500-fold selectivity for BRD4(1) over EP300. Orally administered 38 achieves a complete inhibition of tumor growth with a tumor growth inhibition (TGI) of 99.7% accompanied by good tolerability. |
资助项目 | National Natural Science Foundation of China[81973166] ; National Natural Science Foundation of China[91753207] ; National Natural Science Foundation of China[21702218] ; National Natural Science Foundation of China[81773568] ; National Natural Science Foundation of China[91853205] ; National Natural Science Foundation of China[81625022] ; National Natural Science Foundation of China[81821005] ; National Key R&D Program of China[2018YFA0508200] ; 1000-Youth Talents Plan ; Science and Technology Commission of Shanghai Municipality[17QA1405000] ; Science and Technology Commission of Shanghai Municipality[18431907100] ; Science and Technology Commission of Shanghai Municipality[19XD1404700] ; K.C. Wong Education Foundation ; Youth innovation promotion association[2017333] ; National Science and Technology Major Project[2018ZX09711002-004-012] ; National Science and Technology Major Project[2018ZX09711002006-001] ; National Science and Technology Major Project[2018ZX09711002-008-005] |
WOS关键词 | BRD4 ; FAMILY ; IDENTIFICATION ; CANDIDATE |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
出版者 | AMER CHEMICAL SOC |
WOS记录号 | WOS:000529170200010 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/280570] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Luo, Cheng; Zhou, Bing |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Dept Med Chem, State Key Lab Drug Res, Shanghai 201203, Peoples R China 2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 3.Chinese Acad Sci, Drug Discovery & Design Ctr, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China 4.Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China |
推荐引用方式 GB/T 7714 | Li, Zizhou,Xiao, Senhao,Yang, Yaxi,et al. Discovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitors[J]. JOURNAL OF MEDICINAL CHEMISTRY,2020,63(8):3956-3975. |
APA | Li, Zizhou.,Xiao, Senhao.,Yang, Yaxi.,Chen, Chao.,Lu, Tian.,...&Zhou, Bing.(2020).Discovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitors.JOURNAL OF MEDICINAL CHEMISTRY,63(8),3956-3975. |
MLA | Li, Zizhou,et al."Discovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitors".JOURNAL OF MEDICINAL CHEMISTRY 63.8(2020):3956-3975. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论